[1] Mellon RD, Simone AF, Rappaport BA. Use of anesthetic agents in neonates and young children [J]. Anesth Analg, 2007, 104(3): 509-520. [2] Sury MR, Fairweather K. The effect of melatonin on sedation of children undergoing magnetic resonance imaging [J]. Br J Anaesth, 2006, 97(2): 220-225. [3] Harrison D, Loughnan P, Manias E, et al. Utilization of analgesics, sedatives, and pain scores in infants with a prolonged hospitalization: a prospective descriptive cohort study [J]. Int J Nurs Stud, 2009, 46(5): 624-632. [4] Layangool T, Sangtawesin C, Kirawittaya T, et al. A comparison of oral chloral hydrate and sublingual midazolam sedation for echocardiogram in children [J]. J Med Assoc Thai, 2008, 91 (Suppl 3): S45-52. [5] Liu N, Fan GG, Yu B, et al. Effect of slight sedation with chloral hydrate on the BOLD response of children s visual cortex: a self-control fMRI study [J]. Chin J Med Imaging Technol, 2008, 24(12): 1901-1904. [6] 潘庆军,刘渊. 麻醉药的抗炎抗感染功效及其作用靶点研究进展[J]. 中国临床药理学与治疗学, 2012, 17(8): 940-943. [7] Zhu M, Ackerman JJ, Yablonskiy DA. Body and brain temperature coupling: the critical role of cerebral blood flow [J]. J Comp Physiol B, 2009, 179(6): 701-710. [8] Uematsu M, Takasawa M, Hosoi R, et al. Uncoupling of flow and metabolism by chloral hydrate: a rat in-vivo autoradiographic study [J]. Neuroreport, 2009, 20(3): 219-222. [9] Yuksel BC, Serdar SE, Tuncel A, et al. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock [J]. Eur Surg Res, 2009, 43(2): 219-227. [10] Pan Q, Liu Y, Zheng J, et al. Protective effect of chloral hydrate against lipopolysaccharide/ D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice [J]. Int Immunopharmacol, 2010, 10(8): 967-977. [11] Haslett C, Savill J. Why is apoptosis important to clinicians [J] ? BMJ, 2001, 322(7301): 1499-1500. [12] Medina-Gomez G, Vidal-Puig A. Adipose tissue as a therapeutic target in obesity [J]. Endocrinol Nutr, 2009, 56(8): 404-411. [13] Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege [J]. Science, 1995, 270 (5239): 1189-1192. [14] Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis [J]. Nat Rev Immunol, 2010, 10(1): 36-46. [15] 李仪奎. 中药血清药理学实验方法的若干问题[J]. 中药新药与临床药理, 1999, 10(2): 95-98. [16] Fukuyama H, Adachi M, Suematsu S, et al. Requirement of Fas expression in B cells for tolerance induction [J]. Eur J Immunol, 2002, 32(1): 223-230. [17] Rothstein TL. Inducible resistance to Fas-mediated apoptosis in B cells [J]. Cell Res, 2000, 10(4): 245-266. [18] Tsutsui H, Kayagaki N, Kuida K, et al. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice [J]. Immunity, 1999, 11(3): 359-367. [19] Hohlbaum AM, Gregory MS, Ju ST, et al. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors [J]. J Immunol, 2001, 167(11): 6217-6224. [20] Li HL, Wang AB, Zhang R, et al. A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages [J]. J Cell Physiol, 2006, 208(2): 307-318. [21] Fukui M, Imamura R, Umemura M. et al. Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1 beta release [J]. J Immunol, 2003, 171(4): 1868-1874. |